Serum Apolipoprotein B Levels and Apolipoprotein B/Apolipoprotein A1 Ratio as Predictors of Dyslipidemia Risk in Patients Treated with Second-Generation Antipsychotics: A Retrospective Cohort Study
Baseline serum ApoB levels and the ApoB/ApoA1 ratio are valuable risk markers for dyslipidemia in patients treated with SGAs.
Authors
- Jiajun Zhang Jiajun Zhang (ORCID: https://orcid.org/0000-0003-1268-3796)
- Zhongqing Huang (ORCID: https://orcid.org/0009-0009-6532-5598)
- Wenyong Wang (ORCID: https://orcid.org/0000-0003-4095-547X)
- Jian-Ming Yang
- Weina Li (ORCID: https://orcid.org/0009-0000-9463-8790)
Institutions
- Zhongshan People's Hospital (CN)
Publication Details
- Journal
- Neuropsychiatric Disease and Treatment
- Published
- 2025-12-01
- DOI
- https://doi.org/10.2147/ndt.s564450
- Primary Topic
- Lipoproteins and Cardiovascular Health
- Type
- article
- Field-Weighted Citation Impact
- 0.00